[1]
D. S. H. Bell and T. Jerkins, “Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease”, acbr, vol. 9, no. 5, pp. 392–395, Sep. 2025.